[1]
“FUNDAMENTAL PARADIGMS IN CLINICAL PHARMACOLOGY: A DUAL PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF POLYPHARMACY IN CHRONIC METABOLIC DISORDERS”, Res. Jou. Ana.Inv., vol. 7, no. 5, pp. 1–8, May 2026, doi: 10.17605/.